Bloomberg Markets & Finance via Youtube


Dec.03 — Moderna says its shot has the potential for “durable immunity” and Pfizer has scaled back production targets for its dose. Bloomberg’s Michelle Cortez reports on “Bloomberg Daybreak: Asia.”

READ ALSO  Cloud mining - In search of Greenland’s rare earths | Europe